Folate
{{chembox | Name = Folic acid | ImageFile = Folicacid2.png | ImageSize = 250px | ImageName = Folic acid | IUPACName = (2S)-2-[(4-{[(2-amino-4-hydroxypteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid | OtherNames = N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid; pteroyl-L-glutamic acid; Vitamin B9; Vitamin M; Folacin | Section1 = ! colspan=2 style="background: #f8eaba; text-align: center;" |Identifiers
|-
|
|
|-
|
|
|-
| ECHA InfoCard | 100.000.381 |-
|
|
|- | RTECS number
|
- LP5425000
|-
|
|
|-
| colspan="2" |
- C1=CC(=CC=C1C(=O)NC
(CCC(=O)O)C(=O)O)
NCC2=CN=C3C(=N2)
C(=O)N=C(N3)N
|- | Section2 = ! colspan=2 style="background: #f8eaba; text-align: center;" |Properties
|-
|
| C19H19N7O6
|- | Molar mass
| 441.404 g·mol−1
|- | Appearance | yellow-orange crystalline powder |-
| Melting point
| 250 °C (523 K), decomp.
|-
|
| 0.0016 mg/ml (25 °C) |-
| Acidity (pKa) | 1st: 2.3, 2nd: 8.3 |- | Section7 = ! colspan=2 style="background: #f8eaba; text-align: center;" |Hazards
|- | colspan=2 style="text-align:left; background-color:#eaeaea;" | Occupational safety and health (OHS/OSH): |- |-
| style="padding-left:1em;" |
| non-toxic, non-flammable
|- }}
Folic acid (also known as vitamin B9[1] or folacin) and folate (the naturally occurring form), as well as pteroyl-L-glutamic acid and pteroyl-L-glutamate, are forms of the water-soluble vitamin B9. Vitamin B9 (folic acid and folate inclusive) is essential to numerous bodily functions ranging from nucleotide biosynthesis to the remethylation of homocysteine. It is especially important during periods of rapid cell division and growth. Both children and adults require folic acid to produce healthy red blood cells and prevent anemia.[2] Folate and folic acid derive their names from the Latin word folium (which means "leaf").
A lack of dietary folic acid leads to folate deficiency (FD).
Folate in foods and other sources
Leafy vegetables such as spinach, asparagus, turnip greens, lettuces, dried or fresh beans and peas, fortified cereal products, sunflower seeds and certain other fruits and vegetables are rich sources of folate. Liver and liver products also contain high amounts of folate, as does baker's yeast. Some breakfast cereals (ready-to-eat and others) are fortified with 25% to 100% of the recommended dietary allowance (RDA) for folic acid. A table of selected food sources of folate and folic acid can be found at the USDA National Nutrient Database for Standard Reference.[3] Folic acid is added to grain products in many countries, and in these countries fortified products make up a significant source of folate [4]. Because of the difference in bioavailability between supplemented folic acid and the different forms of folate found in food, the dietary folate equivalent (DFE) system was established. 1 DFE is defined as 1 μg of dietary folate, or 0.6 μg of folic acid supplement. This is reduced to 0.5 μg of folic acid if the supplement is taken on an empty stomach.[5]
History
A key observation by researcher Lucy Wills in 1931 led to the identification of folate as the nutrient needed to prevent anemia during pregnancy. Dr. Wills demonstrated that anemia could be reversed with brewer's yeast. Folate was identified as the corrective substance in brewer's yeast in the late 1930s and was first isolated in spinach leaves by Mitchell and others in 1941 [6]. Bob Stokstad isolated the pure crystalline form in 1943, and was able to determine its chemical structure while working at the Lederle Laboratories of the American Cyanamid Company[7]. This led to the subsequent synthesis of folic acid in 1945, by Dr. Yellapragada Subbarao and many others[8].
Biological roles
DNA and cell division
Folate is necessary for the production and maintenance of new cells.[9] It is especially important during periods of rapid cell division and growth such as infancy and pregnancy. Folate is needed to synthesize DNA bases (most notably thymine, but also purine bases) and also needed for DNA replication. Thus, folate deficiency hinders DNA synthesis and cell division, affecting, most notably, bone marrow and cancer, both of which participate in rapid cell division. RNA transcription, and subsequent protein synthesis, are less affected by folate deficiency, as the mRNA can be recycled and used again (as opposed to DNA synthesis where a new genomic copy must be created). Since folate deficiency limits cell division, erythropoiesis, production of red blood cells is hindered and leads to megaloblastic anemia which is characterized by large immature red blood cells. This pathology results from persistently thwarted attempts at normal DNA replication, DNA repair, and cell division, and produces abnormally large cells (megaloblasts) with abundant cytoplasm capable of RNA and protein synthesis, but with clumping and fragmentation of nuclear chromatin. Some of these large cells, although immature, are released early from the marrow in an attempt to compensate for the anemia caused by lack of red blood cells.[10] Both adults and children need folate to make normal red blood cells and prevent anemia.[11] Deficiency of folate in pregnant women has been implicated in neural tube defects; therefore, many developed countries have implemented mandatory folic acid fortification.
Biochemistry of DNA base and amino acid production
In the form of a series of tetrahydrofolate (THF) compounds, folate derivatives are substrates in a number of single-carbon-transfer reactions, and also are involved in the synthesis of dTMP (2′-deoxythymidine-5′-phosphate) from dUMP (2′-deoxyuridine-5′-phosphate). It is a substrate for an important reaction that involves vitamin B12 and it is necessary for the synthesis of DNA, and so required for all dividing cells.[12]
The pathway leading to the formation of tetrahydrofolate (FH4) begins when folate (F) is reduced to dihydrofolate (DHF) (FH2), which is then reduced to THF. Dihydrofolate reductase catalyses the last step.[13] Vitamin B3 in the form of NADPH is a necessary cofactor for both steps of the synthesis.
Methylene-THF (CH2FH4) is formed from THF by the addition of methylene groups from one of three carbon donors: formaldehyde, serine, or glycine. Methyl tetrahydrofolate (CH3-THF) can be made from methylene-THF by reduction of the methylene group with NADPH. It is important to note that Vitamin B12 is the only acceptor of methyl-THF. There is also only one acceptor for methyl-B12 which is homocysteine in a reaction catalyzed by homocysteine methyltransferase. This is important because a defect in homocysteine methyltransferase or a deficiency of B12 can lead to a methyl-trap of THF and a subsequent deficiency[14]. Thus, a deficiency in B12 can generate a large pool of methyl-THF that is unable to undergo reactions and will mimic folate deficiency. Another form of THF, formyl-THF or folinic acid) results from oxidation of methylene-THF or is formed from formate donating formyl group to THF. Finally, histidine can donate a single carbon to THF to form methenyl-THF.
In other words:
- folate → dihydrofolate → tetrahydrofolate ↔ methylene-THF → methyl-THF
Overview of drugs that interfere with folate reactions
A number of drugs interfere with the biosynthesis of folic acid and THF. Among them are the dihydrofolate reductase inhibitors such as trimethoprim, pyrimethamine and methotrexate; the sulfonamides (competitive inhibitors of para-aminobenzoic acid in the reactions of dihydropteroate synthetase).
The National Health and Nutrition Examination Survey (NHANES III 1988–91) and the Continuing Survey of Food Intakes by Individuals (1994–96 CSFII) indicated that most adults did not consume adequate folate.[15][16] However, the folic acid fortification program in the United States has increased folic acid content of commonly eaten foods such as cereals and grains, and as a result diets of most adults now provide recommended amounts of folate equivalents.[17]
Human reproduction
Folic acid is an important nutrient for women who may become pregnant. Adequate folate intake during the periconceptional period, the time right before and just after a woman becomes pregnant, helps protect against a number of congenital malformations including neural tube defects (which are the most notable birth defects that occur from folate deficiency).[18] Neural tube defects (NTDs) result in malformations of the spine (spina bifida), skull, and brain (anencephaly). The risk of neural tube defects is significantly reduced when supplemental folic acid is consumed in addition to a healthy diet prior to and during the first month following conception.[19][20] The protective effect of folate during pregnancy goes beyond NTDs. Supplementation with folic acid has been shown to reduce the risk of congenital heart defects, cleft palate, limb defects, and urinary tract anomalies [21] Women who could become pregnant are advised to eat foods fortified with folic acid or take supplements in addition to eating folate-rich foods to reduce the risk of some serious birth defects. Taking 400 micrograms of synthetic folic acid daily from fortified foods and/or supplements has been suggested. The RDA for folate equivalents for pregnant women is 600-800 micrograms, twice the normal RDA of 400 micrograms for women who are not pregnant[22]
Recent research has shown that it is also very important for men who are planning on fathering children, reducing chromosomal defects in their sperm.[23]
Health issues
Heart disease
Adequate concentrations of folate, vitamin B12, or vitamin B6 may decrease the circulating level of homocysteine, an amino acid normally found in blood. There is evidence that an elevated homocysteine level is an independent risk factor for heart disease and stroke.[24] The evidence suggests that high levels of homocysteine may damage coronary arteries or make it easier for blood clotting cells called platelets to clump together and form a clot.[25] However, there is currently no evidence available to suggest that lowering homocysteine with vitamins will reduce risk of heart disease. Clinical intervention trials are needed to determine whether supplementation with folic acid, vitamin B12 or vitamin B6 can lower the risk of developing coronary heart disease. The NORVIT trial suggests that folic acid supplementation may do more harm than good.[26]
As of 2006, studies have shown that giving folic acid to reduce levels of homocysteine does not result in clinical benefit. One of these studies suggests that folic acid in combination with B12 may even increase some cardiovascular risks.[27][28][29]
However a 2005 study found that 5 mg. of folate daily over a three-week period reduced pulse pressure by 4.7 mmHg. compared with a placebo, and concluded that[30]
- Folic acid is a safe and effective supplement that targets large artery stiffness and may prevent isolated systolic hypertension.
Also, as a result of new research, "heart experts" at Johns Hopkins Medical Center reported in March 2008 [31] in favour of therapeutic folate, although they cautioned that it is premature for people to begin to self-medicate by taking high doses of folic acid."
Stroke
Folic acid appears to reduce the risk of stroke. The reviews indicate only that in some individuals the risk of stroke appears to be reduced, but a definite recommendation regarding supplementation beyond the current recommended daily allowance has not been established for stroke prevention.[32] Observed stroke reduction is consistent with the reduction in pulse pressure produced by folate supplementation of 5 mg per day, since hypertension is a key risk factor for stroke.
Cancer
The association between folate and cancer appears to be complex.[33] It has been suggested that folate may help prevent cancer, as it is involved in the synthesis, repair, and functioning of DNA, and a deficiency of folate may result in damage to DNA that may lead to cancer.[34] Some investigations have proposed that good levels of folic acid may be related to lower risk of esophageal, stomach, and ovarian cancer, but benefices of folic acid against cancer may depend on when it is taken and on individual conditions. In addition folic acid may not be helpful, and could even be damaging, in people who already are suffering from cancer or from a precancerous condition. Conversely, it has been suggested that excess folate may promote tumor initiation.[35] Diets great in folate are associated with decreased risk of colorectal cancer; some studies show an association which is stronger for folate from foods alone than for folate from foods and supplements,[36] while other studies find that folate from supplements is more effective due to greater bioavailability[37] and a 2007 randomized clinical trial found that folate supplements did not reduce the risk of colorectal adenomas.[38] A 2006 prospective study of 81,922 Swedish adults found that diets great in folate from foods, but not from supplements, were associated with a reduced risk of pancreatic cancer.[39]
Most epidemiologic studies suggest that diets high in folate are associated with decreased risk of breast cancer, but results are not uniformly consistent: one broad cancer screening trial reported a potential harmful effect of much folate intake on breast cancer risk, suggesting that routine folate supplementation should not be recommended as a breast cancer preventive,[40] but a 2007 Swedish prospective study found that much folate intake was associated with lear incidence of postmenopausal breast cancer.[41] A 2008 study has shown no significant effect of folic acid on overall risk of total invasive cancer or breast cancer among women.[42]
In men folic acid supplementation appears to double the risk of prostate cancer.[43]
The cancer drug methotrexate is designed to inhibit the metabolism of folic acid. Folic acid may interact unexpectedly with the cancer drug fluorouracil. The exact mechanism of interaction is unknown.[44]
Antifolates
Folate is important for cells and tissues that rapidly divide.[9] Cancer cells divide rapidly, and drugs that interfere with folate metabolism are used to treat cancer. The antifolate methotrexate is a drug often used to treat cancer because it inhibits the production of the active form of THF from the inactive dihydrofolate (DHF). Unfortunately, methotrexate can be toxic,[45][46][47] producing side effects such as inflammation in the digestive tract that make it difficult to eat normally. Also, bone marrow depression (inducing leukopenia and thrombocytopenia), acute renal and hepatic failure have been reported.
Folinic acid, under the drug name leucovorin, is a form of folate (formyl-THF) that can help "rescue" or reverse the toxic effects of methotrexate.[48] Folinic acid is not the same as folic acid. Folic acid supplements have little established role in cancer chemotherapy.[49][50] There have been cases of severe adverse effects of accidental substitution of folic acid for folinic acid in patients receiving methotrexate cancer chemotherapy. It is important for anyone receiving methotrexate to follow medical advice on the use of folic or folinic acid supplements. The supplement of folinic acid in patients undergoing methotrexate treatment is to give non rapidly dividing cells enough folate to maintain normal cell functions. The amount of folate given will be depleted by rapidly dividing cells (cancer) very fast and so will not negate the effects of methotrexate. Low dose methotrexate is used to treat a wide variety of non-cancerous diseases such as rheumatoid arthritis, lupus, scleroderma, psoriasis, asthma, sarcoidoisis, primary biliary cirrhosis, and inflammatory bowel disease.[51] Low doses of methotrexate can deplete folate stores and cause side effects that are similar to folate deficiency. Both high folate diets and supplemental folic acid may help reduce the toxic side effects of low dose methotrexate without decreasing its effectiveness.[52][53] Anyone taking low dose methotrexate for the health problems listed above should consult with a physician about the need for a folic acid supplement.
While the role in folate as a cancer treatment is well established its long term effectiveness is diminished by cellular response. In response to decreased THF the cell begins to transcribe more DHF reductase, the enzyme that reduces DHF to THF. Because methotrexate is a competitive inhibitor of DHF reductase increased concentrations of DHF reductase can overcome the drugs inhibition.
Depression
Some evidence links a shortage of folate with depression.[54] There is some limited evidence from randomised controlled trials that using folic acid in addition to antidepressants, specifically SSRIs, may have benefits.[55] Research at the University of York and Hull York Medical School has found a link between depression and low levels of folate.[56] One study by the same team involved 15,315 subjects.[57] However, the evidence is probably too limited at present for this to be a routine treatment recommendation.
Memory and mental agility
In a 3-year trial on 818 people over the age of 50, short-term memory, mental agility, and verbal fluency were all found to be better among people who took 800 micrograms of folic acid daily, twice the current RDA, than those who took placebo. The study was reported in The Lancet on 20 January 2007.[58]
Fertility
Folate is necessary for fertility in both men and women. In men, it contributes to spermatogenesis. In women, on the other hand, it contributes to oocyte maturation, implantation, placentation, in addition to the general effects of folic acid and pregnancy. Therefore, it is necessary to receive sufficient amounts through the diet, in order to avoid subfertility.[59]
Macular degeneration
A substudy of the Women's Antioxidant and Folic Acid Cardiovascular Study published in 2009 reports that use of a nutritional supplement that contains folic acid, pyridoxine, and cyanocobalamin decreased the risk of developing age-related macular degeneration by 34%.[60]
Folic acid supplements and masking of B12 deficiency
There has been concern about the interaction between vitamin B12 and folic acid.[61] Folic acid supplements can correct the anemia associated with vitamin B12 deficiency. Unfortunately, folic acid will not correct changes in the nervous system that result from vitamin B12 deficiency. Permanent nerve damage could theoretically occur if vitamin B12 deficiency is not treated. Therefore, intake of supplemental folic acid should not exceed 1000 micrograms (1000 µg or 1 mg) per day to prevent folic acid from masking symptoms of vitamin B12 deficiency. In fact, to date the evidence that such masking actually occurs is scarce, and there is no evidence that folic acid fortification in Canada or the U.S. has increased the prevalence of vitamin B12 deficiency or its consequences.[62]
However one recent study has demonstrated that high folic or folate levels when combined with low B12 levels are associated with significant cognitive impairment among the elderly.[63]
In any case, it is important for older adults to be aware of the relationship between folic acid and vitamin B12 because they are at greater risk of having a vitamin B12 deficiency. If you are 50 years of age or older, ask your physician to check your B12 status before you take a supplement that contains folic acid.[64]
Health risk of too much folic acid
The risk of toxicity from folic acid is low.[65] The Institute of Medicine has established a tolerable upper intake level (UL) for folate of 1 mg for adult men and women, and a UL of 800 µg for pregnant and lactating (breast-feeding) women less than 18 years of age. Supplemental folic acid should not exceed the UL to prevent folic acid from masking symptoms of vitamin B12 deficiency.[66]
Research suggests high levels of folic acid can interfere with some antimalarial treatments.[67]
A 10,000-patient study at Tufts University in 2007 concluded that excess folic acid worsens the effects of B12 deficiency and in fact may affect the absorption of B12. [68]
Dietary fortification
Since the discovery of the link between insufficient folic acid and neural tube defects (NTDs), governments and health organizations worldwide have made recommendations concerning folic acid supplementation for women intending to become pregnant.
This has led to the introduction in many countries of fortification, where folic acid is added to flour with the intention of everyone benefiting from the associated rise in blood folate levels. This is controversial, with issues having been raised concerning individual liberty, and the masking effect of folate fortification on pernicious anaemia (vitamin B12 deficiency). However, several western countries now fortify their flour, along with a number of Middle Eastern countries and Indonesia. Mongolia and a number of ex-Soviet republics are amongst those having widespread voluntary fortification; about five more countries (including Morocco, the first African country) have agreed but not yet implemented fortification. To date, no EU country has yet mandated fortification.[69]
Australia
There has been previous debate in Australia regarding the inclusion of folic acid in products such as bread and flour.[70]
Australia and New Zealand have jointly agreed to fortification though the Food Standards Australia New Zealand. Australia will fortify all flour from 18 September 2009.[71] Although the food standard covers both Australia and New Zealand, Australian government official has stated it is up to New Zealand to decide whether to implement it in New Zealand, and they will watch with interest.[72].
The requirement is 0.135 mg of folate per 100g of bread.
Canada
In 2003, a Hospital for Sick Children, University of Toronto, research group published findings showing that the fortification of flour with folic acid in Canada has resulted in a dramatic decrease in neuroblastoma, an early and very dangerous cancer in young children.[73] In 2009, further evidence from McGill University showed a 6.2% decrease per year in the birth prevalence of severe congenital heart defects.[74]
New Zealand
New Zealand was going to fortify bread (excluding organic and unleavened varieties) from 18 September 2009 but has opted to wait until more research is done.[75]
The Association of Bakers [76] and the Green Party [77]have opposed mandatory fortifiction, describing it as "mass medication". Food Safety Minister Kate Wilkinson reviewed the decision to fortify in July 2009, citing links between overconsumption of folate with cancer [78]. The New Zealand Government is reviewing whether it will continue with the mandatory introduction of folic acid to bread.[79]
United Kingdom
There has been previous debate in the United Kingdom regarding the inclusion of folic acid in products such as bread and flour.[80]
The Food Standards Agency has recommended fortification.[81][82][83]
United States
The United States Public Health Service recommends an extra 0.4 mg/day, which can be taken as a pill. However, many researchers believe that supplementation in this way can never work effectively enough since about half of all pregnancies in the U.S. are unplanned and not all women will comply with the recommendation.
In 1996, the United States Food and Drug Administration (FDA) published regulations requiring the addition of folic acid to enriched breads, cereals, flours, corn meals, pastas, rice, and other grain products.[84][85] This ruling took effect on January 1, 1998, and was specifically targeted to reduce the risk of neural tube birth defects in newborns.[86] There are concerns that the amount of folate added is insufficient [87]. In October 2006, the Australian press claimed that U.S. regulations requiring fortification of grain products were being interpreted as disallowing fortification in non-grain products, specifically Vegemite (an Australian yeast extract containing folate). The FDA later said the report was inaccurate, and no ban or other action was being taken against Vegemite.[88]
Because the folic acid fortification program took effect, fortified foods have become a major source of folic acid in the American diet. The Centers for Disease Control and Prevention in Atlanta, Georgia used data from 23 birth defect registries that cover about half of United States births and extrapolated their findings to the rest of the country. This data indicates that since the addition of folic acid in grain-based foods as mandated by the FDA, the rate of neural tube defects dropped by 25% in the United States[89]. The results of folic acid fortification on the rate of neural tube defects in Canada have also been positive, showing a 46% reduction in prevalence of NTDs,[90] The magnitude of reduction was proportional to the prefortification rate of NTDs, essentially removing geographical variations in rates of NTDs seen in Canada before fortification.
See also
References
- ^ Ural, Serdar H. (2008-11). "Folic Acid and Pregnancy". Kid's Health.
{{cite web}}
: Check date values in:|date=
(help) - ^ "Dietary Supplement Fact Sheet: Folate". Office of Dietary Supplements, National Institutes of Health.
- ^ "Reports by Single Nutrients". USDA. 2009-02-13. Retrieved 2009-03-19.
{{cite web}}
: Cite has empty unknown parameter:|coauthors=
(help) - ^ Dietrich M, Brown CJ & Block G (2005) The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States. J Am Coll Nutr 24, 266-274.
- ^ Suitor CW & Bailey LB (2000) Dietary folate equivalents: interpretation and application. J Am Diet Assoc 100, 88-94.
- ^ Mitchell HK, Snell EE, Williams RJ (1941). "The concentration of "folic acid"". J Am Chem Soc. 63 (8): 2284. doi:10.1021/ja01853a512.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Hoffbrand AV & Weir DG (2001) The history of folic acid. Br J Haematol 113, 579-589.
- ^ Angier RB, Boothe JH, Hutchings BL, Mowat JH, Semb J, Stokstad EL, Subbarow Y, Waller CW, Cosulich DB, Fahrenbach MJ, Hultquist ME, Kuh E, Northey EH, Seeger DR, Sickels JP & Smith JM, Jr. (1945) Synthesis of a Compound Identical with the L. Casei Factor Isolated from Liver. Science 102, 227-228.
- ^ a b Kamen B (1997). "Folate and antifolate pharmacology". Seminars in oncology. 24 (5 Suppl 18): S18–30–9. PMID 9420019.
- ^ Smith C, Lieberman M, Marks DB, Marks AD (2007). Marks' essential medical biochemistry. Hagerstwon, MD: Lippincott Williams & Wilkins. ISBN 0-7817-9340-8.
{{cite book}}
: CS1 maint: multiple names: authors list (link) - ^ Zittoun J (1993). "Anemias due to disorder of folate, vitamin B12 and transcobalamin metabolism". La Revue du praticien. 43 (11): 1358–63. PMID 8235383. Template:Fr icon
- ^ Goh YI & Koren G (2008) Folic acid in pregnancy and fetal outcomes. J Obstet Gynaecol 28, 3-13.
- ^ EC 1.5.1.3
- ^ Hoffbrand AV & Weir DG (2001) The history of folic acid. Br J Haematol 113, 579-589.
- ^ Alaimo K, McDowell MA, Briefel RR, Bischof AM, Caughman CR, Loria CM, Johnson CL (1994). "Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91". Advance Data (258): 1–28. PMID 10138938.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Raiten DJ, Fisher KD (1995). "Assessment of folate methodology used in the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994)". The Journal of Nutrition. 125 (5): 1371S–1398S. PMID 7738698.
- ^ Lewis CJ, Crane NT, Wilson DB, Yetley EA (1999). "Estimated folate intakes: data updated to reflect food fortification, increased bioavailability, and dietary supplement use". The American Journal of Clinical Nutrition. 70 (2): 198–207. PMID 10426695.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA (1995). "Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects". Epidemiology. 6 (3): 219–226. doi:10.1097/00001648-199505000-00005. PMID 7619926.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Mulinare J, Cordero JF, Erickson JD, Berry RJ (1988). "Periconceptional use of multivitamins and the occurrence of neural tube defects". Journal of the American Medical Association. 260 (21): 3141–3145. doi:10.1001/jama.260.21.3141. PMID 3184392.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, Willett W (1989). "Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects". Journal of the American Medical Association. 262 (20): 2847–2852. doi:10.1001/jama.262.20.2847. PMID 2478730.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Goh YI & Koren G (2008) "Folic acid in pregnancy and fetal outcomes", J. Obstet. Gynaecol. 28:3–13.
- ^ Health Professionals Recommendations, Folic Acid, NCBDDD, CDC
- ^ Medical News: Extra Folate for Men May Reduce Birth Defects - in Primary Care, Diet & Nutrition from MedPage Today
- ^ Refsum H, Ueland PM, Nygard O, Vollset SE (1998). "Homocysteine and cardiovascular disease". Annual Review of Medicine. 49 (1): 31–62. doi:10.1146/annurev.med.49.1.31. PMID 9509248.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Malinow MR (1995). "Plasma homocyst(e)ine and arterial occlusive diseases: A mini-review". Clinical Chemistry. 41 (1): 173–6. PMID 7813076.
- ^ NORVIT Trial- High dose B vitamins do not lower stroke or MI risk
- ^ Zoungas S, McGrath BP, Branley P, Kerr PG, Muske C, Wolfe R, Atkins RC, Nicholls K, Fraenkel M, Hutchison BG, Walker R, McNeil JJ (2006). "Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial". J Am Coll Cardiol. 47 (6): 1108–16. doi:10.1016/j.jacc.2005.10.064. PMID 16545638.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ "Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease". N Engl J Med. 2006. PMID [http://content.nejm.org/cgi/reprint/NEJMoa060900v1.pdf Full text PDF 16531613 [http://content.nejm.org/cgi/reprint/NEJMoa060900v1.pdf Full text PDF]].
{{cite journal}}
: Check|pmid=
value (help); External link in
(help)|pmid=
- ^ Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K (2006). "Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction". N Engl J Med: 1578. doi:10.1056/NEJMoa055227. PMID [http://content.nejm.org/cgi/reprint/NEJMoa055227v1.pdf Full text PDF 16531614 [http://content.nejm.org/cgi/reprint/NEJMoa055227v1.pdf Full text PDF]].
{{cite journal}}
: Check|pmid=
value (help); External link in
(help)CS1 maint: multiple names: authors list (link)|pmid=
- ^ Williams C, Kingwell BA, Burke K, McPherson J, Dart AM (2005). "Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype". Am J Clin Nutr. 82 (1): 26–31. PMID 16002796.
{{cite journal}}
: Unknown parameter|day=
ignored (help); Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Brief, high doses of folate blunt damage from heart attack
- ^ BBC Folic acid 'reduces stroke risks' 31 May 2007
- ^ Van Guelpen B (2007). "Folate in colorectal cancer, prostate cancer and cardiovascular disease". Scand J Clin Lab Invest. 67 (5): 459–73. doi:10.1080/00365510601161513. PMID 17763182.
- ^ Jennings E (1995). "Folic acid as a cancer-preventing agent". Med Hypotheses. 45 (3): 297–303. doi:10.1016/0306-9877(95)90121-3. PMID 8569555.
- ^ Kim YI (2004). "Will mandatory folic acid fortification prevent or promote cancer?". Am J Clin Nutr. 80 (5): 1123–8. PMID 15531657.
{{cite journal}}
: Unknown parameter|day=
ignored (help); Unknown parameter|month=
ignored (help) - ^ Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ (2005). "Folate intake and colorectal cancer risk: a meta-analytical approach". Int J Cancer. 113 (5): 825–8. doi:10.1002/ijc.20648. PMID 15499620.
{{cite journal}}
: More than one of|pages=
and|page=
specified (help)CS1 maint: multiple names: authors list (link) - ^ Giovannucci E, Stampfer MJ, Colditz GA; et al. (1998). "Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study". Ann. Intern. Med. 129 (7): 517–24. PMID 9758570.
{{cite journal}}
: Explicit use of et al. in:|author=
(help)CS1 maint: multiple names: authors list (link) - ^ Cole BF, Baron JA, Sandler RS; et al. (2007). "Folic acid for the prevention of colorectal adenomas: a randomized clinical trial". JAMA. 297 (21): 2351–9. doi:10.1001/jama.297.21.2351. PMID 17551129.
{{cite journal}}
: Explicit use of et al. in:|author=
(help)CS1 maint: multiple names: authors list (link) - ^ Larsson SC, Håkansson N, Giovannucci E, Wolk A (2006). "Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men". J Natl Cancer Inst. 98 (6): 407–13. doi:10.1093/jnci/djj094. PMID 16537833.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Kim YI (2006). "Does a high folate intake increase the risk of breast cancer?". Nutr Rev. 64 (10 Pt 1): 468–75. doi:10.1301/nr.2006.oct.468-475. PMID 17063929.
- ^ Ericson U, Sonestedt E, Gullberg B, Olsson H, Wirfält E (2007). "High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmö Diet and Cancer cohort". Am J Clin Nutr. 86 (2): 434–43. PMID 17684216.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Zhang SM, Cook NR, Albert CM, Gaziano JM, Buring JE, Manson JE (2008). "Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial". JAMA. 300 (17): 2012–21. doi:10.1001/jama.2008.555. PMID 18984888.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ "MedlinePlus: Folic Acid Supplements Raise Prostate Cancer Risk".
- ^ "folic-acid and Xeloda Interactions"
- ^ Rubio IT, Cao Y, Hutchins LF, Westbrook KC, Klimberg VS (1998). "Effect of glutamine on methotrexate efficacy and toxicity". Annals of Surgery. 227 (5): 772–8. doi:10.1097/00000658-199805000-00018. PMID 9605669.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Wolff JE, Hauch H, Kuhl J, Egeler RM, Jurgens H (1998). "Dexamethasone increases hepatotoxicity of MTX in children with brain tumors". Anticancer Research. 18 (4B): 2895–9. PMID 9713483.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Kepka L, De Lassence A, Ribrag V, Gachot B, Blot F, Theodore C, Bonnay M, Korenbaum C, Nitenberg G (1998). "Successful rescue in a patient with high dose methotrexate-induced nephrotoxicity and acute renal failure". Leukemia & Lymphoma. 29 (1–2): 205–9. doi:10.3109/10428199809058397. PMID 9638991.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Branda RF, Nigels E, Lafayette AR, Hacker M. (1998). "Nutritional folate status influences the efficacy and toxicity of chemotherapy in rats". Blood. 92 (7): 2471–6. PMID 9746787.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Shiroky JB (1997). "The use of folates concomitantly with low-dose pulse methotrexate". Rheumatic Diseases Clinics of North America. 23 (4): 969–80. doi:10.1016/S0889-857X(05)70369-0. PMID 9361164.
- ^ Keshava C, Keshava N, Whong WZ, Nath J, Ong TM (1998). "Inhibition of methotrexate-induced chromosomal damage by folinic acid in V79 cells". Mutation Research. 397 (2): 221–8. PMID 9541646.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Morgan SL, Baggott JE Template:Section:Chapter reference after author
- ^ Morgan SL, Baggott JE, Alarcon GS (1997). "Methotrexate in rheumatoid arthritis: folate supplementation should always be given". BioDrugs. 8 (1): 164–75.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) Click here to request reprint from publisher - ^ Morgan SL, Baggott JE, Lee JY, Alarcon GS (1998). "Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: Implications for cardiovascular disease prevention". Journal of Rheumatology. 25 (3): 441–6. PMID 9517760.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Coppen A, Bolander-Gouaille C. (2005). "Treatment of depression: time to consider folic acid and vitamin B12". Journal of Psychopharmacology. 19 (1): 59–65. doi:10.1177/0269881105048899. PMID 15671130.
- ^ Taylor MJ, Carney SM, Goodwin GM, Geddes JR. (2004). "Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials". Journal of Psychopharmacology. 18 (2): 251–6. doi:10.1177/0269881104042630. PMID 15260915.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Gilbody S, Lewis S, Lightfoot T (2007). "Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review". American Journal of Epidemiology. 165 (1): 1–13. PMID 17074966.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Gilbody S, Lightfoot T, Sheldon T (2007). "Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity". Journal of Epidemiology and Community Health. 61 (7): 631–637. PMID 17568057.
{{cite journal}}
: Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Durga J, van Boxtel MP, Schouten EG; et al. (2007). "Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial". Lancet. 369 (9557): 208–16. doi:10.1016/S0140-6736(07)60109-3. PMID 17240287.
{{cite journal}}
: Explicit use of et al. in:|author=
(help); Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ Ebisch IM, Thomas CM, Peters WH, Braat DD, Steegers-Theunissen RP (2007). "The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility". Hum Reprod Update. 13 (2): 163–74. doi:10.1093/humupd/dml054. PMID 17099205.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Christen WG, Glynn RJ, Chew EY, Albert CM, Manson JE (2009). "Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study". Arch Intern Med. 169 (4): 335–41. doi:10.1001/archinternmed.2008.574. PMID 19237716.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Scott JM (1999 May). "Folate and vitamin B12". Proc Nutr Soc. 2 (58): 441–8. PMID 10466189.
{{cite journal}}
: Check date values in:|year=
(help)CS1 maint: year (link) - ^ Mills JL, Von Kohorn I, Conley MR, Zeller JA, Cox C, Williamson RE, Dufour DR (2003 Jun). "Low vitamin B12 concentrations in patients without anemia: the effect of folic acid fortification of grain". Am J Clin Nutr. 6 (77): 1474–7. PMID 12791626.
{{cite journal}}
: Check date values in:|year=
(help)CS1 maint: multiple names: authors list (link) CS1 maint: year (link) - ^ Morris MS, Jacques PF, Rosenberg IH, Selhub J (2007). "Folate and vitamin B12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification". Am J Clin Nutr. 85 (1): 193–200. PMC 1828842. PMID 17209196.
{{cite journal}}
: Unknown parameter|day=
ignored (help); Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - ^ BBC News | HEALTH | Folic acid 'heart boost for elderly'
- ^ Hathcock JN. (1997). "Vitamins and minerals: efficacy and safety". American Journal of Clinical Nutrition. 66 (2): 427–37. PMID 9250127.
- ^ Baggott JE, Morgan SL, HaT, Vaughn WH, Hine RJ (1992). "Inhibition of folate-dependent enzymes by non-steroidal anti-inflammatory drugs". Biochemical Journal. 282 (Pt 1): 197–202. PMID 1540135.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ BBC Folic acid 'hinders malaria drug' 21 October 2006
- ^ Foodproductiondaily [1]
- ^ Russell A (2006). "The UK campaign on folic acid and flour fortification". Cerebrospinal Fluid Res. 3 (Suppl 1): S33. doi:10.1186/1743-8454-3-S1-S33. PMC 1716791.
{{cite journal}}
: CS1 maint: unflagged free DOI (link) - ^ "Bread fortification 'not justified'". The Sydney Morning Herald. 29 July 2006.
- ^ "Bread to be fortified with folic acid". NZ Herald. 2007-06-22. Retrieved 2009-07-13.
{{cite news}}
: Unknown parameter|coauthors=
ignored (|author=
suggested) (help) - ^ "Bread additive call 'up to NZ'". Retrieved 2009-07-15.
- ^ French AE, Grant R, Weitzman S, Ray JG, Vermeulen MJ, Sung L, Greenberg M, Koren G. Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther 2003; 74: 288-94.
- ^ "Prevelance of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada". Brit Med J. 338 (7705): 1261. 2009. doi:10.1136/bmj.b1673.
{{cite journal}}
: Text "Ionescu-Ittu R, Marelli AJ, Mackie AS, Pilote L" ignored (help) - ^ "Bread to be fortified with folic acid". NZ Herald. 2007-06-22. Retrieved 2009-07-13.
{{cite news}}
: Unknown parameter|coauthors=
ignored (|author=
suggested) (help) - ^ "Work Starts on Wilkinson's Mass Medication Plan" (Press release). Association Of Bakers. 2009-07-08. Retrieved 2009-07-13.
- ^ "NZ should push pause on folic fortification" (Press release). Green Party. 2009-07-09. Retrieved 2009-07-13.
- ^ "Bakers, Govt battle over folic acid". NZ Herald. 2009-07-08. Retrieved 2009-07-13.
{{cite news}}
: Unknown parameter|coauthors=
ignored (|author=
suggested) (help) - ^ "Govt reviewing folic acid policy". Stuff. Retrieved 15 July 2009.
- ^ BBC 'Put folic acid in bread' 2000-01-13
- ^ FSA (2007-05-17). "Board recommends mandatory fortification". Retrieved 2007-05-18.
- ^ "Backing for folic acid in bread". Retrieved 2007-05-18.
- ^ BBC Experts back folic acid in flour 11 May 2007
- ^ Malinow MR, Duell PB, Hess DL, Anderson PH, Kruger WD, Phillipson BE, Gluckman RA, Block PC, Upson BM (1998). "Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease". New England Journal of Medicine. 338 (15): 1009–15. doi:10.1056/NEJM199804093381501. PMID 9535664.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN, Weir DG, Scott JM (1997). "Minimum effective dose of folic acid for food fortification to prevent neural-tube defects". Lancet. 350 (9092): 1666–9. doi:10.1016/S0140-6736(97)07247-4. PMID 9400511.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Crandall BF, Corson VL, Evans MI, Goldberg JD, Knight G, Salafsky IS (1998). "American College of Medical Genetics statement on folic acid: fortification and supplementation". American Journal of Medical Genetics. 78 (4): 381. doi:10.1002/(SICI)1096-8628(19980724)78:4<381::AID-AJMG16>3.0.CO;2-E. PMID 9714444.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ "FDA muffed chance to reduce birth defects". Boston Globe. 6 January 2004.
- ^ "US denies Vegemite ban". 25 October 2006.
- ^ Centers for Disease Control and Prevention (CDC) (2004). "Spina bifida and anencephaly before and after folic acid mandate--United States, 1995-1996 and 1999-2000". Morbidity and Mortality Weekly Report. 53 (17): 362–5. PMID 15129193.
- ^ De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, Evans JA, Van den Hof MC, Zimmer P, Crowley M, Fernandez B, Lee NS & Niyonsenga T (2007). "Reduction in neural-tube defects after folic acid fortification in Canada". N Engl J Med. 357: 135–142.
{{cite journal}}
: CS1 maint: multiple names: authors list (link)
Bibliography
- This article contains information from the public domain resource at http://www.cc.nih.gov/ccc/supplements/folate.html
- Herbert V (1999). "Folic Acid". In Shils ME, Olson J, Shike M, Ross AC (ed.). Modern nutrition in health and disease (9th ed.). Baltimore: Williams and Wilkins. ISBN 0-683-30769-X.
{{cite book}}
: CS1 maint: multiple names: editors list (link) - Food and Nutrition Board, Institute of Medicine (1998). Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline / a report of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline and Subcommittee on Upper Reference Levels of Nutrients. Washington, D.C.: National Academy Press. ISBN 0-309-06554-2.
- Dietary Guidelines Advisory Committee, Agricultural Research Service, United States Department of Agriculture (USDA). Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2000. http://www.ars.usda.gov/dgac
External links
- Jane Higdon, "Folic Acid", Micronutrient Information Center, Linus Pauling Institute, Oregon State University
- Health Canada article about folic acid
- US Public Health Service information page on folic acid
- Oakley GP (2002). "Delaying folic acid fortification of flour". BMJ. 324 (7350): 1348–9. doi:10.1136/bmj.324.7350.1348. PMC 1123313. PMID 12052788.
{{cite journal}}
: Unknown parameter|month=
ignored (help) - Salvi VS (2003). "Folic acid and birth defects". J Postgrad Med. 49 (3): 195–6. PMID 14597778.
{{cite journal}}
: Unknown parameter|day=
ignored (help); Unknown parameter|month=
ignored (help) - Folic Acid The Vitamin That Does Almost Everything-U.C Berkeley Wellness Letter April 2003
- BMC Pregnancy and Childbirth 2004: no vitamin B12 problems in Canada after folic acid fortification
- The primary prevention of birth defects: Multivitamins or folic acid?
- Mills JL, Von Kohorn I, Conley MR; et al. (2003). "Low vitamin B12 concentrations in patients without anemia: the effect of folic acid fortification of grain". Am J Clin Nutr. 77 (6): 1474–7. PMID 12791626.
Despite evidence that folic acid exposure has increased dramatically since food fortification began, this population showed no evidence of an increase in low vitamin B12 concentrations without anemia. If confirmed, these results would indicate that food fortification has not caused a major increase in masking of vitamin B12 deficiency.
{{cite journal}}
: Explicit use of et al. in:|author=
(help); Unknown parameter|day=
ignored (help); Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link) - Folic acid may help prevent throat cancer
- Folic acid may help treat bipolar disorder
- Biochemistry links
- Folate biosynthesis (early stages)
- Folate biosynthesis (later stages)
- Folate coenzymes
- C1 metabolism with folate
- Formylation, hydroxymethylation and methylation using folate
- IUPAC nomenclature of folate related compounds